Proguanil is an antimalarial drug belonging to the class of biguanides. It is primarily used in the prevention and treatment of malaria, especially Plasmodium falciparum, in combination with other antimalarials such as atovaquone (commonly marketed as Malarone®).
Proguanil is a prodrug—it is metabolized in the liver to its active form, cycloguanil, which inhibits Plasmodium dihydrofolate reductase (DHFR). This inhibition blocks DNA synthesis and replication in the parasite, preventing its development in the human body.
Proguanil is taken orally, and is often used for malaria prophylaxis in travelers to endemic regions.
Parent: Proguanil / Chlorhexidine
Parent: Proguanil
Parent: Proguanil
Parent: Proguanil
Parent: Proguanil
Parent: Proguanil
Parent: Proguanil Hydrochloride / Proguanil
Impurities in proguanil may arise from synthetic processes, degradation, or storage conditions, and must be monitored per ICH guidelines to ensure product quality and safety.
Process-Related Impurities
Degradation Impurities
Elemental Impurities
Analytical Techniques for Impurity Detection
Common side effects include: